Implant Sciences filed with the U.S. Bankruptcy Court a monthly operating report for March 2017.
For the month, the Debtors reported an $1.9 million net loss on zero net revenue and $384,436 in total reorganization expenses, $353,461 in professional fees and $19,184 in administrative expenses. Cash at the beginning of March 2017 was $74.6 million and $72.8 million at month’s end, with negative net cash flow of $1.9 million. Cash disbursements for the month were $1.9 million on zero in cash receipts.
More on manufacturing industry bankruptcies.